Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial

被引：0

作者：

Paller, Amy ^{[1
]}

Blauvelt, Andrew ^{[2
]}

Soong, Weily ^{[3
]}

Imafuku, Shinichi ^{[4
]}

Hong, Chih-Ho ^{[5
]}

Schuttelaar, Marie L. A. ^{[6
]}

Amoudruz, Petra ^{[7
]}

Kurbasic, Azra ^{[7
]}

Soldbro, Lise ^{[7
]}

Lophaven, Katja ^{[7
]}

Cork, Michael ^{[8
]}

Bewley, Anthony ^{[9
]}

Simpson, Eric L. ^{[10
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[2] Oregon Med Res Ctr, Portland, OR USA

[3] Allervie Hlth Alabama Allergy & Asthma Ctr, Birmingham, AL USA

[4] Fukuoka Univ, Fukuoka, Japan

[5] Univ British Columbia, Vancouver, BC, Canada

[6] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands

[7] LEO Pharma AS, Ballerup, Denmark

[8] Univ Sheffield, Sheffield, S Yorkshire, England

[9] Barts Hlth NHS Trust, London, England

[10] Oregon Hlth & Sci Univ, Portland, OR USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

190

引用

页码：E90 / E91

页数：2

共 50 条

[1] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
Paller, A.
Blauvelt, A.
Soong, W.
Imafuku, S.
Hong, C.
Schuttelaar, M. L. A.
Amoudruz, P.
Kurbasic, A.
Soldbro, L.
Lophaven, K.
Schneider, S.
Cork, M.
Bewley, A.
Simpson, E. L.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E145 - E146
[2] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis The Phase 3 ECZTRA 6 Randomized Clinical Trial
Paller, Amy S.
Flohr, Carsten
Cork, Michael
Bewley, Anthony
Blauvelt, Andrew
Hong, H. Chih-ho
Imafuku, Shinichi
Schuttelaar, Marie L. A.
Simpson, Eric L.
Soong, Weily
Arlert, Petra
Lophaven, Katja Wendicke
Kurbasic, Azra
Soldbro, Lise
Vest, Natacha Strange
Wollenberg, Andreas
[J]. JAMA DERMATOLOGY, 2023, 159 (06) : 596 - 605
[3] Tralokinumab provides progressive and sustained efficacy in adolescents with moderate-to-severe atopic dermatitis: a post-hoc analysis of the ECZTRA 6 trial
Simpson, Eric L.
Wollenberg, Andreas
Kurbasic, Azra
Tindberg, Ann-Marie
Soldbro, Lise
Paller, Amy S.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[4] Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial
Wiseman, Marni
Armstrong, April W.
Soung, Jennifer
Albrecht, Lorne
Lomaga, Mark
Papp, Kim A.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB178 - AB178
[5] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis
Merola, Joseph F.
Butler, Daniel C.
Mark, Thomas
Schneider, Shannon
Kim, Yestle
Abuabara, Katrina
[J]. JAMA DERMATOLOGY, 2023, 159 (10) : 1119 - 1123
[6] Tralokinumab prevents flares in moderate-to-severe atopic dermatitis: post hoc analyses of a randomized phase III clinical trial (ECZTRA 3)
Silverberg, J. I.
Barbarot, S.
Welzel, J.
Ameen, M.
Thyssen, J. P.
Lomaga, M.
Olsen, C. Kurre
Mark, T.
Corriveau, J.
Merola, J. F.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E79 - E79
[7] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Wollenberg, Andreas
Paller, Amy S.
Bewley, Anthony
Cork, Michael
Hong, Chih-Ho
Soong, Weily
Oland, Christian Bjerregard
Taveira, Christian Moreira
Gjerum, Le
Blauvelt, Andrew
[J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
[8] SAFETY OF TRALOKINUMAB IN PAEDIATRIC PATIENTS AGED 12-17 WITH MODERATE-TO-SEVERE AROPIC DERMATITIS: RESULTS FROM THE PHASE 3 ECZTRA 6 TRIAL
Wollenberg, Andreas
Cork, Michael J.
Flohr, Carsten
Bewley, Anthony
Blauvelt, Andrew
Hong-H, Chih-Ho
Imafuku, Shinichi
Schuttelaar, Marie-Louise Anna
Simpson, Eric
Soong, Weily
Amoudruz, Petra
Lophaven, Katja
Kurbasic, Azra
Soldbro, Lise
Vest, Natacha
Paller, Amy
[J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 58 - 58
[9] Efficacyand Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial (vol 159, pg 596, 2023)
Shin, L.
Kole, L. C. S.
Peebles, J. K.
[J]. JAMA DERMATOLOGY, 2023, 159 (06) : 673 - 673
[10] EFFICACY AND SAFETY OF TRALOKINUMAB IN A KOREAN SUBPOPULATION OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A SUBANALYSIS OF ECZTRA 2, A PHASE 3, MONOTHERAPY, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL
Kim, Kyu Han
Son, Sang Wook
Lee, Yang Won
Simpson, Eric L.
Kuznetsova, Alexandra
Cho, Sang Hyun
[J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 63 - 63

← 1 2 3 4 5 →